At Nano Biotherapeutics, our mission is to treat acute and chronic inflammation and tissue injury in the heart and lungs using albumin nanoparticle mediated drug delivery.

Nano Biotherapeutics, Inc is a NIH Small Business Technology Transfer (STTR) supported start-up located in the Illinois Medical District, near downtown Chicago. The technology originated from years of research at the University of Illinois College of Medicine and our drug development efforts are conducted by a distinguished group of scientists and consultants with expertise in immunology, nano technology, physiology, veterinary science and clinical areas such as acute respiratory distress syndrome (ARDS) and myocardial infarction.